Financials
Financial year 2025
JDS Pharma from La Louvière, company number BE1012963476, closed financial year 2025 with a result of € 30,345 after tax. For that financial year JDS Pharma recorded a gross margin of € 40,475 and equity of € 43,542. Compared with financial year 2024, the result moved from € 10,197 to € 30,345. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 43,542
▲ 230% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 30,345
▲ 198% vs 2024
Profit after tax over the fiscal year.
€ 59,517
▲ 295% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 40,542.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,005
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,245
▲ 87% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 13,256 | € 40,475 | ▲ 205% |
| Profit after taxes | € 10,197 | € 30,345 | ▲ 198% |
| Equity | € 13,197 | € 43,542 | ▲ 230% |
| Total debts | € 12,895 | € 20,263 | ▲ 57% |
| Cash | € 15,052 | € 59,517 | ▲ 295% |
| Retained profit | € 10,197 | € 40,542 | ▲ 298% |
| Balance sheet total | € 26,092 | € 63,805 | ▲ 145% |
By gross margin, JDS Pharma ranks 8th of 8 companies with main activity “Detailhandel in farmaceutische producten” in La Louvière that publish figures (fiscal year 2025).
Key figures of JDS Pharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about JDS Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to JDS Pharma?
What happened at JDS Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 30,345 (▲ 198% vs 2024). filed late Source: NBB ↗
- New establishment in La Louvière. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 10,197 profit in 2024 to € 30,345 profit in 2025.
Paid € 11,051 in corporate taxes since 2024.
Best year ever: 2025, with € 30,345 profit.
Establishments
Establishment units
Physical locations of this company
Rue de l'Infante Isabelle(H-A) 68
7110 La Louvière
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in La Louvière
Same main activity (Detailhandel in farmaceutische producten), 7 active companies in La Louvière, largest first.
€ 723,308 gross margin · 2025
€ 520,104 gross margin · 2025
€ 512,644 gross margin · 2025
€ 409,346 gross margin · 2025
€ 161,800 gross margin · 2025
€ 119,641 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DI SCIACCA Julie(fondateur) 100%
Details
- Company number
- 1012.963.476
- VAT number
- BE 1012.963.476
- Registered office
- Rue de l'Infante Isabelle(H-A) 68, 7110 La Louvière
- Names & denominations
- JDS Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 August 2024
- Peppol
- Active · Active since 2 Jun 2026
- Activities · NACE
Detailhandel in farmaceutische producten